Standout Papers

Metabolite profiles and the risk of developing d... 1997 2026 2006 2016 2.3k
  1. Metabolite profiles and the risk of developing diabetes (2011)
    Thomas J. Wang, Martin G. Larson et al. Nature Medicine
  2. Obesity and the Risk of Heart Failure (2002)
    Satish Kenchaiah, Jane C. Evans et al. New England Journal of Medicine
  3. Arterial Stiffness and Cardiovascular Events (2010)
    Gary F. Mitchell, Shih‐Jen Hwang et al. Circulation
  4. Hemodynamic Patterns of Age-Related Changes in Blood Pressure (1997)
    Stanley S. Franklin, William Gustin et al. Circulation
  5. Long-Term Trends in the Incidence of and Survival with Heart Failure (2002)
    Daniel Levy, Satish Kenchaiah et al. New England Journal of Medicine
  6. Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease (2001)
    Ramachandran S. Vasan, Martin G. Larson et al. New England Journal of Medicine
  7. Lifetime Risk for Development of Atrial Fibrillation (2004)
    Donald M. Lloyd‐Jones, Thomas J. Wang et al. Circulation
  8. Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality (2003)
    Thomas J. Wang, Martin G. Larson et al. Circulation
  9. Impact of Reduced Heart Rate Variability on Risk for Cardiac Events (1996)
    Hisako Tsuji, Martin G. Larson et al. Circulation
  10. Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease? (1999)
    Stanley S. Franklin, Shehzad Akbar Khan et al. Circulation
  11. Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women (2004)
    Gary F. Mitchell, Helen Parise et al. Hypertension
  12. Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death (2004)
    Thomas J. Wang, Martin G. Larson et al. New England Journal of Medicine
  13. Lifetime Risk for Developing Congestive Heart Failure (2002)
    Donald M. Lloyd‐Jones, Martin G. Larson et al. Circulation
  14. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study (2015)
    Renate B. Schnabel, Xiaoyan Yin et al. The Lancet
  15. Obesity and Systemic Oxidative Stress (2003)
    John F. Keaney, Martin G. Larson et al. Arteriosclerosis Thrombosis and Vascular Biology
  16. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction (1999)
    Ramachandran S. Vasan, Martin G. Larson et al. Journal of the American College of Cardiology
  17. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis (2019)
    Ulf Ekelund, Jakob Tarp et al. BMJ
  18. Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study (1999)
    Bruce F. Culleton, Martin G. Larson et al. Annals of Internal Medicine
  19. Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death (2006)
    Thomas J. Wang, Philimon Gona et al. New England Journal of Medicine
  20. Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging? (2001)
    Stanley S. Franklin, Martin G. Larson et al. Circulation
  21. Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men (2002)
    Ramachandran S. Vasan, Alexa Beiser et al. JAMA
  22. Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age (2006)
    Donald M. Lloyd‐Jones, Eric Leip et al. Circulation
  23. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) (1999)
    Jagmeet Singh, Jane C. Evans et al. The American Journal of Cardiology
  24. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. (1994)
    Martin G. Larson, Emelia J. Benjamin et al. Circulation
  25. Comparisons of Five Health Status Instruments for Orthopedic Evaluation (1990)
    Matthew H. Liang, Anne H. Fossel et al. Medical Care
  26. Incidence and Prognosis of Syncope (2002)
    Elpidoforos S. Soteriades, Jane C. Evans et al. New England Journal of Medicine
  27. Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension (2012)
    Bernhard M. Kaess, Jian Rong et al. JAMA
  28. Impact of Obesity on Plasma Natriuretic Peptide Levels (2004)
    Thomas J. Wang, Martin G. Larson et al. Circulation
  29. Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress (2007)
    Karla M. Pou, Joseph M. Massaro et al. Circulation
  30. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study (2001)
    Ramachandran S. Vasan, Martin G. Larson et al. The Lancet
  31. Prevalence and Clinical Outcome of Mitral-Valve Prolapse (1999)
    Lisa A. Freed, Daniel Levy et al. New England Journal of Medicine
  32. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus (1989)
    Matthew H. Liang, Martin G. Larson et al. Arthritis & Rheumatism
  33. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency (1999)
    Bruce F. Culleton, Martin G. Larson et al. Kidney International
  34. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death (1998)
    Agha W. Haider, Martin G. Larson et al. Journal of the American College of Cardiology
  35. Predicting the 30-Year Risk of Cardiovascular Disease (2009)
    Michael Pencina, Ralph B. D’Agostino et al. Circulation
  36. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: Design, Recruitment, and Initial Examination (2007)
    Greta Lee Splansky, David P. Corey et al. American Journal of Epidemiology
  37. A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community (2003)
    Thomas J. Wang, Joseph M. Massaro et al. JAMA
  38. Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study (2008)
    Naomi M. Hamburg, Michelle J. Keyes et al. Circulation
  39. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) (1992)
    Alex Sagie, Martin G. Larson et al. The American Journal of Cardiology
  40. Atrial Fibrillation Begets Heart Failure and Vice Versa (2016)
    Rajalakshmi Santhanakrishnan, Na Wang et al. Circulation
  41. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research (1985)
    Matthew H. Liang, Martin G. Larson et al. Arthritis & Rheumatism
  42. Rare independent mutations in renal salt handling genes contribute to blood pressure variation (2008)
    Weizhen Ji, Jia Nee Foo et al. Nature Genetics
  43. Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction (2009)
    Douglas S. Lee, Philimon Gona et al. Circulation
  44. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans (2011)
    Eugene P. Rhee, Susan Cheng et al. Journal of Clinical Investigation
  45. Positron emission tomography in Alzheimer's disease (1986)
    Ranjan Duara, C. L. Grady et al. Neurology
  46. Prognostic Utility of Novel Biomarkers of Cardiovascular Stress (2012)
    Thomas J. Wang, Kai C. Wollert et al. Circulation
  47. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction (2018)
    Connie W. Tsao, Asya Lyass et al. JACC Heart Failure
  48. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study (2018)
    Laila Stærk, Biqi Wang et al. BMJ

Immediate Impact

1 by Nobel laureates 10 from Science/Nature 96 standout
Sub-graph 1 of 21

Citing Papers

A metabolomics pipeline for the mechanistic interrogation of the gut microbiome
2021 StandoutNature
Human blood vessel organoids as a model of diabetic vasculopathy
2019 StandoutNature

Works of Martin G. Larson being referenced

Directed Non-targeted Mass Spectrometry and Chemical Networking for Discovery of Eicosanoids and Related Oxylipins
2019
Clinical and Genetic Correlates of Circulating Angiopoietin-2 and Soluble Tie-2 in the Community
2010

Author Peers

Author Last Decade Papers Cites
Martin G. Larson 51911 9801 8782 12342 10350 580 86.7k
Emelia J. Benjamin 68687 7120 11958 11568 10426 766 98.8k
Ramachandran S. Vasan 55741 12518 14727 13453 16332 941 105.1k
Aaron R. Folsom 26297 7078 9311 10864 8438 859 73.5k
John Deanfield 30921 4868 10281 11062 8025 540 56.9k
Russell P. Tracy 22740 7792 19152 13036 19934 663 85.4k
William B. Kannel 69673 8969 14583 22477 11099 475 125.2k
Daniel Levy 88384 13178 13402 24628 11026 807 138.9k
Donald M. Lloyd‐Jones 33587 3984 6845 17512 5636 716 66.3k
Lewis H. Kuller 19039 5975 10323 10797 13598 999 76.0k
Gregg C. Fonarow 76391 5730 16690 17156 5345 1.8k 109.2k

All Works

Loading papers...

Rankless by CCL
2026